ResearcherMaastricht UniversityNo recent work listed

Lotte Wieten

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4503-1623; OpenAlex author ID A5057297422. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer org… Last author DOI 10.3389/fimmu.2023.1133796 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nicky A. Beelen · 1 shared paper, 2023 · strength 0.20
- Paper Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response again… DOI 10.3389/fimmu.2023.1133796 ↗
Steven W.M. Olde Damink · 1 shared paper, 2023 · strength 0.20
- Paper Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response again… DOI 10.3389/fimmu.2023.1133796 ↗
Merel R. Aberle · 1 shared paper, 2023 · strength 0.20
- Paper Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response again… DOI 10.3389/fimmu.2023.1133796 ↗
Sander S. Rensen · 1 shared paper, 2023 · strength 0.20
- Paper Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response again… DOI 10.3389/fimmu.2023.1133796 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.